M10, a novel derivative of Myricetin, prevents ulcerative colitis and colorectal tumor through attenuating robust endoplasmic reticulum stress. [electronic resource]
Producer: 20190129Description: 889-899 p. digitalISSN:- 1460-2180
- Alanine -- analogs & derivatives
- Animals
- Anticarcinogenic Agents -- pharmacology
- Colitis, Ulcerative -- prevention & control
- Colon -- drug effects
- Colorectal Neoplasms -- metabolism
- Disease Models, Animal
- Endoplasmic Reticulum Stress -- drug effects
- Flavonoids -- pharmacology
- Hydroxyquinolines -- pharmacology
- Inflammation -- metabolism
- Inflammation Mediators -- metabolism
- Interleukin-6 -- metabolism
- Intestinal Mucosa -- drug effects
- Male
- Mice
- Mice, Inbred C57BL
- NF-kappa B -- metabolism
- STAT3 Transcription Factor -- metabolism
- Signal Transduction -- drug effects
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.